Role of early detection and pharmacotherapy in chronic obstructive pulmonary disease (Q37754917)

22 August 2017

title

Role of early detection and pharmacotherapy in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

22 August 2017

0 references

1 reference

Philip Diaz

1

1 reference

22 August 2017

Aaron Bruns

series ordinal

2

1 reference

22 August 2017

Mahasti Rittinger

series ordinal

3

1 reference

22 August 2017

Steven Kadiev

series ordinal

4

1 reference

22 August 2017

publication date

1 December 2008

1 reference

Expert Review of Respiratory Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

779-789

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Attaining a correct diagnosis of COPD in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Developing COPD: a 25 year follow up study of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Pulmonary biomarkers in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Cell death, remodeling, and repair in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Spirometry and smoking cessation advice in general practice: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

A randomized trial of smoking cessation interventions in general practice in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD: results of the detection, intervention, and monitoring of COPD and asthma program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.6.779

21 January 2018

Identifiers

DOI

10.1586/17476348.2.6.779

1 reference

22 August 2017

1 reference